| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 12/16/2004 | US20040253628 Using modified grampositive bacteria as bioreactors for fermentation of lysine; for use in medicine, cosmetics and animal feeds |
| 12/16/2004 | US20040253621 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 12/16/2004 | US20040253615 NOD nucleic acids and polypeptides |
| 12/16/2004 | US20040253612 Selection of proteins using RNA-protein fusions |
| 12/16/2004 | US20040253606 Using tumor marker gene transcription profile as diagnostic tool in detection of cell proliferative disorders of soft tissue; monitoring efficacy of antitumor agents |
| 12/16/2004 | US20040253601 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism |
| 12/16/2004 | US20040253594 Using polymorphic nucleotide sequences to identify regions/quantitative trait loci for natural resistance-associated macrophage protein (NRAMP) genes; prognosticating parasitic infection resistance |
| 12/16/2004 | US20040253592 Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host |
| 12/16/2004 | US20040253460 Functionalized silicon compounds and methods for their synthesis and use |
| 12/16/2004 | US20040253242 immunoglobulins or fragments comprising complementarity determining regions (CDR) having segments replaced with human brain natriuretic peptides, glucagon-like peptides, exendins, glucagons, pituitary adenylate cyclase-activating polypeptides and/or mimetics; immunotherapy |
| 12/16/2004 | US20040253215 Methods and compositions for treating disorders |
| 12/16/2004 | US20040253210 replication-defective adenovirus type 7 that expresses one or more HIV polypeptides for use in stimulating an immune response to HIV-1; adenovirus serotype 7 cosmid vector; gene therapy |
| 12/16/2004 | CA2540692A1 Oligonucleotide synthesis with alternative solvents |
| 12/16/2004 | CA2528500A1 Porcine cmp-n-acetylneuraminic acid hydroxylase gene |
| 12/16/2004 | CA2525975A1 Humanized antibodies that recognize beta amyloid peptide |
| 12/15/2004 | EP1486565A1 Combination PDGF, KGF, IGF, and IGFBP for wound healing |
| 12/15/2004 | EP1485502A2 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof |
| 12/15/2004 | EP1485501A2 Method for generating amplified rna |
| 12/15/2004 | EP1485500A2 Efficient synthesis of protein-oligonucleotide conjugates |
| 12/15/2004 | EP1485480A2 Cd40 splice variants, method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
| 12/15/2004 | EP1485401A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(-2-methoxyl)ethyl modifications |
| 12/15/2004 | EP1485400A2 Human rnase iii and compositions and uses thereof |
| 12/15/2004 | EP1485399A2 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS |
| 12/15/2004 | EP1485398A2 Methods of screening for compounds that modulate hormone receptor activity |
| 12/15/2004 | EP1485395A2 Nucleotide mimics and their prodrugs |
| 12/15/2004 | EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 12/15/2004 | EP1485056A2 Methods of using fet labeled oligonucleotides that include a'5' exonuclease resistant quencher domain and compositions for practicing the same |
| 12/15/2004 | EP0950112A4 Photolabile polymer array synthesis methods |
| 12/15/2004 | EP0666918B1 Production of gamma linolenic acid by a delta-6 desaturase |
| 12/15/2004 | EP0638088B1 Hybrid human/porcine factor viii |
| 12/15/2004 | CN1555414A Plant-derived resistance gene |
| 12/15/2004 | CN1555411A Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 12/15/2004 | CN1555385A Ligands to enhance cellular uptake of biomolecules |
| 12/15/2004 | CN1555268A Therapeutic agents comprising pro-apoptotic proteins |
| 12/15/2004 | CN1554771A C type perfringocin beta-2 toxin mutant gene |
| 12/15/2004 | CN1554763A O-antigen specific nucleotide of E.coli 035 type |
| 12/15/2004 | CN1554762A O-antigen specific nucleotide of E.coli 0147 type |
| 12/15/2004 | CN1554761A O-antigen specific nucleotide of E.coli 0142 type |
| 12/15/2004 | CN1554760A O-antigen specific nucleotide of E.coli 0109 type |
| 12/15/2004 | CN1554759A O-antigen specific nucleotide of E.coli 081 type |
| 12/15/2004 | CN1554758A O-antigen specific nucleotide of E.coli 074 type |
| 12/15/2004 | CN1554757A O-antigen specific nucleotide of E.coli 071 type |
| 12/15/2004 | CN1554756A O-antigen specific nucleotide of E.coli 065 type |
| 12/15/2004 | CN1554755A O-antigen specific nucleotide of E.coli 0144type |
| 12/15/2004 | CN1554754A O-antigen specific nucleotide of E.coli 0139 type |
| 12/15/2004 | CN1554753A O-antigen specific nucleotide of E.coli 0138 type |
| 12/15/2004 | CN1554752A O-antigen specific nucleotide of E.coli 076 type |
| 12/14/2004 | US6831217 C3 plants expressing photosynthetic enzyme of C4 plants |
| 12/14/2004 | US6831168 Aldehyde oxidase gene derived from plant and utilization thereof |
| 12/14/2004 | US6831166 Derivatized oligonucleotides having improved uptake and other properties |
| 12/14/2004 | US6830890 Nucleic acid probe libraries |
| 12/14/2004 | US6830886 Supports for the parallel identification and transcription profiling of polynucleic acids |
| 12/14/2004 | CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom |
| 12/14/2004 | CA2169355C Tumor suppressor protein prb2, related gene products, and dna encoding therefor |
| 12/14/2004 | CA2146320C Antisense oligonucleotide inhibition of the ras gene |
| 12/14/2004 | CA1341468C Preparation of functional human factor viii |
| 12/09/2004 | WO2004106552A1 Dna hybrids and environment cleaning system employing dna hybrids |
| 12/09/2004 | WO2004106551A1 Dna-oxide complex, preparation method thereof and environmental clean-up system using dna-oxide complex |
| 12/09/2004 | WO2004106517A1 Double-stranded nucleic acid |
| 12/09/2004 | WO2004106497A2 Imageable animal model of sars infection |
| 12/09/2004 | WO2004106489A2 Nematode GS-like sequences |
| 12/09/2004 | WO2004106488A2 Gene expression suppression agents |
| 12/09/2004 | WO2004106374A1 Ecdysone receptor ligand-binding domain structure |
| 12/09/2004 | WO2004106373A1 Erythropoietin conjugate compounds with extended half-lives |
| 12/09/2004 | WO2004106357A1 Method and apparatus for recognizing molecular compounds |
| 12/09/2004 | WO2004106356A1 Functionalized nucleotide derivatives |
| 12/09/2004 | WO2004068111A3 Methods and compositions for rna detection and quantitation |
| 12/09/2004 | WO2004047742A3 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 12/09/2004 | WO2004047736A3 Modulation of bcl2-associated athanogene expression |
| 12/09/2004 | WO2004043344A3 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 12/09/2004 | WO2004039319A3 Novel human polypeptides encoded by polynucleotides |
| 12/09/2004 | WO2004018693A3 Method for the production of ketocarotinoids in flower petals on plants |
| 12/09/2004 | WO2004011624A3 Double stranded rna structures and constructs, and methods for generating and using the same |
| 12/09/2004 | WO2004011612A3 Method of detecting and quantifying hepatitis c virus |
| 12/09/2004 | WO2004006866A3 Antifungal therapeutic targets |
| 12/09/2004 | WO2003101283A3 Diagnostics markers for lung cancer |
| 12/09/2004 | US20040250322 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
| 12/09/2004 | US20040249152 Activation of the carboxyl function of a CNA monomer building block, subsequent esterification of this monomer building block with a free hydroxyl function,thereafter assembly of the oligomer by repetitive cycles starting from elimination of the protective group |
| 12/09/2004 | US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 12/09/2004 | US20040249128 Disease detection polypeptides diagnosis, treatment, and prevention of cell proliferative, autoimmune/inflammatory, developmental and neurological disorders |
| 12/09/2004 | US20040248841 Genetic engineered Dna; stability, efficiency; Rna interference |
| 12/09/2004 | US20040248840 Oligomeric compounds for the modulation of ras expression |
| 12/09/2004 | US20040248839 RNAi targeting of viruses |
| 12/09/2004 | US20040248828 Antisense modulation of interleukin 12 p35 subunit expression |
| 12/09/2004 | US20040248795 unlike calpastatin, the peptides of the invention do not target an active cysteine of calpain; protecting neurons against ultraviolet radiation induced cell death |
| 12/09/2004 | US20040248304 Regulatory sequences associated with nematode resistance genes for use in generation of transgenic diseases resistant plants; biological pest control |
| 12/09/2004 | US20040248302 Brassica pyruvate dehydrogenase kinase gene |
| 12/09/2004 | US20040248286 Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof |
| 12/09/2004 | US20040248262 Nucleotide sequences coding lysosomal protein for use treatment of brain and muscular disorders |
| 12/09/2004 | US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation |
| 12/09/2004 | US20040248251 Receptors and membrane associated proteins |
| 12/09/2004 | US20040248246 Compositions and methods for enhancing differential expression |
| 12/09/2004 | US20040248245 Zinc activated ion channel |
| 12/09/2004 | US20040248244 ATM related kinase ATX, nucleic acids encoding same and methods of use |
| 12/09/2004 | US20040248202 Labeled chimeric membrane protein for use as tool in identifying modulators for treatment and prevention of viral infection and cell proliferative disorders |
| 12/09/2004 | US20040248174 Small interfering RNA sequences for use in prevention and treatment of vision defects, inflammation, cardiovascular and cell proliferative disorders; RNA interference; gene expression inhibition |
| 12/09/2004 | US20040248165 Nucleic acid immobilization method and manufacturing method of biosensor using same |
| 12/09/2004 | US20040248163 Microparticle mixture comprised of immobilized oligonucleotides arranged in fiber optic bundle for use in microsphere based flow cytometric bioassays |
| 12/09/2004 | US20040248162 Releasable polymer arrays |
| 12/09/2004 | US20040248157 Nucleotide sequences coding cytokine polypeptides for use in diagnosis, treatment and prevention fof cell proliferative and inflammatory disorders |